Shivom’s international team harness a wealth of diverse experience, skills and perspectives. They have come together behind a common vision: the democratisation of the healthcare industry. The team shares a genuine optimism for the future, entrepreneurial drive and the passionate belief that Shivom will drive the future of genomics and precision medicine. Their dream is for Shivom to become a powerful force for positive social impact globally.
Henry is a global executive with 20+ years of professional experience ranging from early stage venture capital, management consultancy, cross border trade to corporate finance advisory. As a VC, he focused on early stage investments in frontier technologies to include FinTech & blockchain, artificial intelligence and VR/AR while working in Silicon Valley and Asia as a partner at DraperDragon Fund, DFJ Dragon Fund and DragonVenture. Henry also has extensive cross border advisory and corporate finance/investment banking experiences focused in a variety of sectors ranging from information technology, e-gaming, healthcare, automotive, telecommunications to consumer & industrial products. Aside from his current work at Shivom, Henry also serves as an advisor to multiple blockchain / ICOs and tech startups in Silicon Valley; and as a mentor for accelerators & incubators worldwide. Henry also routinely lectures at the Nanyang Technopreneurship Center (NTC), Nanyang Technological University (NTU) and is a Senior Member of the World Education Blockchain Association (WEBA) in Singapore. Henry began his career at McNeil Consumer Products Company, a subsidiary of Johnson & Johnson, and later as a management consultant to Fortune 100 companies while working at Price Waterhouse LLP. Henry holds a BS in Finance from Pennsylvania State University in University Park, PA and an MBA from Duke University Fuqua School of Business in Durham, NC
Axel has over 20 years of Research and Development leadership experience in genomics, epigenetics, biomarker discovery, Bio-IT, aging & longevity. He is the Author of the ‘Blockchain & Healthcare Strategy Guide’, the standard compendium for the healthcare industry. Axel translates scientific discoveries into practical applications to help understand, diagnose & treat complex disorders, but also to promote cutting-edge technologies that could transform precision medicine and the way we age. Axel is also a Member of the Blockchain Research Institute in Toronto. He holds a Ph.D. in Human Genetics from the University of Cologne.
As an experienced executive in early stage biotech and healthtech startups, Natalie focused her efforts across operations, business development, investor relations and R&D. Her career in pharmaceutical and biotechnology drug development is complmented by her PhD from the Faculty of Medicine, University of Toronto, where her work focused on inflammatory and degenerative disease. Additionally she worked on advanced diagnostics and precision medicine strategies, creating new tools for phenotypic patient stratification, encompassing genomics and machine learning approaches. She leads the healthcare operations at the London Chapter of the Government Blockchain Association, and contributes a breadth of experience from 8+ years as a university instructor, and holding multiple board, management and consulting roles in the non-profit sector.
With a background in investment banking and wealth management, Gourish is an accomplished business leader, angel investor and social entrepreneur with a focus on performance, growth, and innovation. He drove 30m$+ revenue in his last venture into a highly competitive marketplace and has founded three successful companies in the digital health space. Through Project Shivom, Gourish combines his deep interest in this sector alongside advocacy for blockchain and distributed ledger technology that can make a transformational difference both for business and for wider society.
As an accomplished professional with a distinguished global professional, academic and charitable record including a broad interdisciplinary scientific education and experience in the areas of NGS medicine, AI, mathematics, pan-omics, epigenetics, clinical drug discovery, start-ups, sales and marketing. He holds a Ph.D. from the University of Oxford, with a research focus on rare diseases. Darrol has sequenced over 7500 whole human genomes from bloods and tissues though to variant and clinical patient decision making.
Nate has 5 years of marketing and communications experience with Silicon Beach, after which he moved to Canada to work with Microsoft and Nintendo. He then went on to develop location-based entertainment opportunities in China and the Middle-East, before moving on to London to launch Cardano’s venture-capital offering. In his downtime, Nate brings a uniquely global lens to his advisory roles within Two Coins Group, Magnetics and Rabbit Communications.
A hustler who loves to challenge boundaries, an independent learner who is always excited about new technological developments happening around the world. Agam co-founded a funded startup in an IOT space. Agam wants to make a meaningful difference to the society through technology and help in the upliftment of the poor. With a certificate course in Entrepreneurship from Stanford, Agam has extensive experience in developing and implementing communication strategies across organizations.
Charles has a degree in Computer Science and a minor in Mathematics from the University of Alabama. He has been in technology for 20 years. One of the veterans from the internet boom era in the late 1990's. He has been in 4 startup companies, including the first high-speed Internet broadband cable modem company, Excite@Home, now Comcast network in the US. He has also worked in technology for financial companies like UBS Hong Kong, UBS Tokyo, JPMorgan Hong Kong, JPMorgan Tokyo, JPMorgan US and Citibank Tokyo. Charles has always had an interest in blockchain technology and experimented with bitcoin mining in 2011.
Azam is an accomplished business leader and social entrepreneur with a focus on performance, growth, and innovation. She has been associated with crypto ICOs that have raised more than $100 million since December 2017. She achieved 2nd & 3rd place in international invention contests in Geneva & Brussels in 2005. Azam is the Canada ambassador for the World Innovations Forum and describes herself as a disruptive force in making a global social impact. She is a regular technology contributor for multiple publications such as Huffington post and STEM related magazines.
As a tech-savvy and subject matter expert in Digital Marketing and SEO industry, Ajit has governed various E-Commerce Sales and Product-based clients, Fortune 500 included. To empower organizations' digital marketing footprints, he seeks a sustainable-based but various challenging strategies and innovative thinking through reconciling global web marketplace to meet positive and scalable outcome for the enterprise.
Amanda is an entrepreneurial HR professional, specialising in start-ups and SMEs who is passionate about people. She has a strong record of introducing policies and procedures which help in the development and progression of companies. She is a confident, commercial and creative practitioner, Assoc CIPD qualified with an adaptable aptitude that enables her to communicate effectively at all levels, identify key stakeholders and work towards achieving strategic goals.
The Shivom Innovation Council is an internal think tank that supports and informs Shivom’s senior management team about future technology, industry trends and strategy. It also helps Shivom prioritise investments, resources and initiatives. The Council is comprised of world-class experts and thought leaders in a variety of key areas including A.I., genomics, business strategy, cryptography, computer science, cybersecurity, telemedicine, IoT, futurology, and precision medicine.
Mr. Rõivas was the prime minister of the Republic of Estonia from 2014 to 2016. He was a member of the 11th, and is currently a member of the 12th term of Estonian Parliament, has chaired the European Union Affairs Committee, and been a member of the Social Affairs and Finance Committees of the Parliament. Mr. Rõivas is globally known as a digital influencer, promoting digitalisation of the governmental and business sectors, digital citizens rights, e-citizenship, e-voting and many other innovative and progressive initiatives.
Father of Telemedicine, Dr. Jay Sanders is a graduate of Harvard Medical School, Dr. Sanders directs the U.S. telemedicine initiatives to the G-8 nations and is a founding member of the American Telemedicine Association. As a pioneer advocate and activist in the field of telemedicine, Dr. Sanders has trail-blazed a new frontier for physicians and the medical profession.
Lithuanian representative at the European Parliament, Antanas Guoga (TonyG) is an entrepreneur, venture capitalist investing in start-ups in the digital area, and philanthropist. Known for his efforts to promote a better climate for entrepreneurship and improving conditions for business opportunities. He is a well-known promoter and advocate of blockchain technology and crypto-currencies.
Founder and Managing Partner of Network Society Ventures, David Orban’s entrepreneurial accomplishments span several companies founded and grown over more than twenty years. An early adopter of blockchain technologies since 2010, he was the first to own Ether during the Ethereum launch. He also led the adoption of Bitcoin and blockchain in start-ups and is an advisor and investor in numerous blockchain companies and funds.
Founder of Advanced Cybersecurity Group, Geoff Hancock has spent 27 years in cybersecurity from Department of Defense and Intelligence community to other governments and global corporations. Over the last ten years, his work has been applying cybersecurity concepts and challenges to Blockchain, Artificial Intelligence, Genetics and Cybersecurity.
Known for his groundbreaking work leading to the creation of the Office of the National Coordinator for Health Information Technology in 2004 in the U.S.A. Dr. William Yasnoff accomplished consultant and national leader in health informatics, his focus is developing and implementing practical, real-world solutions to the most complex and difficult unsolved problems.
Fellow of the Royal College of Psychiatrists, Dr Irshaad Ebrahim Neuropsychiatrist and Sleep Medicine Specialist, is actively involved in clinical research for new treatments for Insomnia, Depression and Anxiety Disorders. He is an early adopter of Blockchain Technology for Healthcare and has recently been appointed to advise several Crypto Funds on their Blockchain Healthcare Strategy
Dr. Kamala K Maddali is an influential leader in precision medicine arena serving on Project Shivom’s innovation council. Dr. Maddali is currently an executive at Cancer Genetics Inc leading the Drug Development Collaborations across the global pharma industry. She holds a Ph.D., in Pharmacology from University of Missouri-Columbia and a DVM Veterinary Medicine from Acharya N.G. Ranga Agricultural University in India.
Her leadership acumen started over a decade ago with her pivotal role in Merck and Co as a biomarker scientist understanding the various pharmacological and toxic effects of the investigational novel drugs across multiple therapeutic areas in Oncology, Neurology and metabolic disorders.
She has played various leadership roles as a “chief scientific commercial liaison” for clinical trial organizations like Quintiles and Quest Diagnostics. Overall, she brings a lot of strategic values from her previous roles and also as an active speaker at various conferences worldwide for biomarkers and companion diagnostics. Her mantra for leadership is to “spread some sunshine” by being passionate and positive about her commitment to patient’s health via novel testing solutions.
Dr. Maddali was the 2016 Healthcare Heroes Finalist Award for “Innovation-Individual” category at NJBIZ. The 10th annual NJBIZ awards paid tribute to individuals and organizations that are making a significant impact on the quality of health care in New Jersey. In an ever-changing health care world, these people and companies that go above and beyond matter more than ever to the residents of the Garden State.
Dr. Maddali also serves as a “Vice Chair” for “Women in Bio (WIB)”-Philadelphia chapter since 2016; promoting leadership, and entrepreneurship for women in the life sciences. Dr. Maddali also serves as a advisory board member for several patient advocacy groups to understand patient perspectives for fostering transformative healthcare collaborations across the healthcare industry.